Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients

被引:82
作者
Sharma, S
Brown, GC
Brown, MM
Hollands, H
Robins, R
Shah, GK
机构
[1] Queens Univ, Hop Hotel Dieu, Cost Effect Ocular Hlth Policy Unit, Dept Ophthalmol, Kingston, ON K7L 5G2, Canada
[2] Queens Univ, Dept Ophthalmol, Kingston, ON, Canada
[3] Queens Univ, Dept Epidemiol, Kingston, ON, Canada
[4] Ctr Evidence Based Hlth Care Econ, Philadelphia, PA USA
[5] Washington Univ, Barnes Retina Inst, St Louis, MO USA
关键词
D O I
10.1136/bjo.86.5.493
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim: To assess the validity of the time trade-off (70) and standard reference gamble (SRG) techniques of utility assessment in patients with retinal disease. A cross section of eligible patients was studied and validity was determined through their relation with two logical constructs, visual acuity and scores from the Visual Function 14 (VF-14) index. Methods: The study consisted of eligible patients presenting to a tertiary retinal facility who completed an interview, All patients had best corrected vision of 20/40 or worse in at least one eye. TTO and SRG utilities, as well as a VF-14 questionnaire, were administered through a standardised interview. Demographic and clinical (including Snellen visual acuity) information was also collected. Results: 323 patients met these study criteria. Significant predictors of TTO utilities in the multivariate analysis were vision in the better seeing eye (p<0.01) and VF-l 4 scores (p<0.01), Significant predictors of standard gamble utilities were also vision in the better seeing eye (p<0.01) and VF-14 scores (p<0.05). Conclusion: Both the standard gamble and TTO methods demonstrate strong validity when evaluated against visual acuity in the better seeing eye and the VF-l 4 score.
引用
收藏
页码:493 / 496
页数:4
相关论文
共 14 条
[1]   Cost-effectiveness of treatment for threshold retinopathy of prematurity [J].
Brown, GC ;
Brown, MM ;
Sharma, S ;
Tasman, W ;
Brown, HC .
PEDIATRICS, 1999, 104 (04) :e47
[2]  
Brown GC, 2000, ARCH OPHTHALMOL-CHIC, V118, P47
[3]   Incremental cost-effectiveness of laser therapy for choroidal neovascularization associated with histoplasmosis [J].
Brown, GC ;
Brown, MM ;
Sharma, S ;
Busbee, B ;
Brown, H .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2000, 20 (04) :331-337
[4]   Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization [J].
Brown, GC ;
Brown, MM ;
Sharma, S ;
Brown, H ;
Tasman, W .
OPHTHALMOLOGY, 2000, 107 (07) :1374-1380
[5]  
GUYATT GH, 1995, J RHEUMATOL, V22, P1188
[6]   MEASURING HEALTH-RELATED QUALITY-OF-LIFE [J].
GUYATT, GH ;
FEENY, DH ;
PATRICK, DL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (08) :622-629
[7]  
Linder M, 1999, ARCH OPHTHALMOL-CHIC, V117, P1611
[8]  
Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227
[9]  
NEUMANN JV, 1947, THEORY GAMES EC BEHA, P641
[10]  
Sharma S, 2000, Curr Opin Ophthalmol, V11, P175, DOI 10.1097/00055735-200006000-00004